Browse Pet Safety Reports
18,045 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 18,045 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product, widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 18,045 FDA veterinary adverse event reports for Horse.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| May 23, 2024 | Horse | Warmblood (unspecified) | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| May 23, 2024 | Horse | Quarter Horse | Omeprazole | Lack of efficacy - NOS | Ongoing |
| May 23, 2024 | Horse | Hanovarian | Ceftiofur Crystalline Free Acid | Injection site swelling; Injection site pain; Swollen limb; Fever; Creased sk... | Ongoing |
| May 23, 2024 | Horse | Horse (unknown) | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| May 23, 2024 | Horse | Quarter Horse | Omeprazole | Lack of efficacy - NOS | Ongoing |
| May 20, 2024 | Horse | Quarter Horse | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| May 20, 2024 | Horse | Warmblood - Dutch, Hanovari... | Pentosan Polysulfate Sodium | Injection site pain; Injection site swelling | Recovered/Normal; Outcome Unknown |
| May 19, 2024 | Horse | Warmblood (unspecified) | N-Butylscopolaminium Bromide | Lack of efficacy - NOS | Recovered/Normal |
| May 19, 2024 | Horse | Arab | Altrenogest Oily Solution | Colic | Recovered/Normal |
| May 17, 2024 | Horse | Thoroughbred | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| May 17, 2024 | Horse | Quarter Horse | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| May 16, 2024 | Horse | Horse (unknown) | Pentosan Polysulfate Sodium | Injection site swelling | Outcome Unknown |
| May 16, 2024 | Horse | Arab | Diclazuril Oral Pellets | Abnormal oestrus NOS; Colic | Ongoing |
| May 16, 2024 | Horse | Horse (unknown) | Ivermectin; Praziquantel | Oral swelling | Outcome Unknown |
| May 15, 2024 | Horse | Unknown | Sodium Hyaluronate | Joint swelling | Outcome Unknown |
| May 15, 2024 | Horse | Horse (unknown) | Detomidine Hydrochloride | Nystagmus; Tremor; Head bobbing | Recovered/Normal |
| May 14, 2024 | Horse | Quarter Horse, Quarter Hors... | Ketamine Hydrochloride | Lack of efficacy - NOS | Recovered/Normal |
| May 14, 2024 | Horse | Miniature | Pergolide Mesylate | Fever; Tachycardia; Hyperventilation; Digestive tract hypermotility; Stress l... | Recovered/Normal |
| May 14, 2024 | Horse | Miniature | Flunixin Meglumine Oral Paste | Fever; Tachycardia; Hyperventilation; Digestive tract hypermotility; Stress l... | Ongoing |
| May 14, 2024 | Horse | Crossbred Equine/horse, She... | Flunixin Meglumine Injectable | Not himself/herself | Recovered/Normal |
| May 14, 2024 | Horse | Paint | Omeprazole | Lack of efficacy - NOS | Ongoing |
| May 13, 2024 | Horse | Haflinger, Quarter Horse, Q... | Ketamine Hydrochloride | Lack of efficacy - NOS; Unrelated death | Recovered/Normal; Euthanized |
| May 13, 2024 | Horse | Horse (unknown) | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| May 11, 2024 | Horse | Horse (unknown) | Detomidine Hydrochloride | Lack of efficacy - NOS | Outcome Unknown |
| May 11, 2024 | Horse | Horse (unknown) | Firocoxib | Pruritus | Outcome Unknown |
| May 11, 2024 | Horse | Quarter Horse | Ceftiofur Crystalline Free Acid | Injection site swelling; Injection site warmth | Ongoing |
| May 10, 2024 | Horse | Horse (unknown) | Pentosan Polysulfate Sodium | Injection site swelling; Reluctant to move | Outcome Unknown |
| May 10, 2024 | Horse | Horse (unknown) | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| May 9, 2024 | Horse | Quarter Horse | Flunixin Meglumine Injectable | Injection site swelling; Injection site pain | Ongoing |
| May 9, 2024 | Horse | Horse (unknown) | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| May 8, 2024 | Horse | Pony (unspecified) | Omeprazole | Lack of efficacy - NOS | Recovered/Normal |
| May 7, 2024 | Horse | Tennessee Walking Horse | Omeprazole | Lack of efficacy - NOS | Ongoing |
| May 7, 2024 | Horse | Warmblood - Dutch | Betavet | Lameness; Joint effusion | Outcome Unknown |
| May 6, 2024 | Horse | Quarter Horse | Domperidone | Diarrhoea | Outcome Unknown |
| May 6, 2024 | Horse | Quarter Horse | Omeprazole | Lack of efficacy - NOS | Ongoing |
| May 6, 2024 | Horse | Quarter Horse | Omeprazole | Lack of efficacy - NOS | Recovered/Normal |
| May 6, 2024 | Horse | Warmblood (unspecified) | Omeprazole | Lack of efficacy - NOS | Recovered/Normal |
| May 5, 2024 | Horse | Horse (unknown) | Xylazine | Lack of efficacy - NOS | Outcome Unknown |
| May 5, 2024 | Horse | Horse (unknown) | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| May 3, 2024 | Horse | Warmblood - Dutch | Clodronate Disodium | Fever; Abnormal serum protein NOS | Outcome Unknown |
| May 3, 2024 | Horse | Horse (unknown) | Ponazuril | Cellulitis; Overdose | Outcome Unknown |
| May 3, 2024 | Horse | Warmblood (unspecified) | Omeprazole | Lack of efficacy - NOS | Ongoing |
| May 3, 2024 | Horse | Paint | Clodronate Disodium | Alopecia local; Excessive sweating; Not himself/herself; Reluctant to move; E... | Outcome Unknown |
| May 3, 2024 | Horse | Horse (other), Horse (unkno... | Xylazine Hydrochloride | Excitation; Seizure NOS; Behavioural disorder NOS; Unrelated death; Lack of e... | Euthanized |
| May 2, 2024 | Horse | Horse (unknown) | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| May 2, 2024 | Horse | Horse (unknown) | Ivermectin; Praziquantel | Unclassifiable adverse event | Outcome Unknown |
| May 2, 2024 | Horse | Horse (unknown) | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| May 1, 2024 | Horse | Thoroughbred | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| May 1, 2024 | Horse | Horse (other) | Ketamine Hydrochloride | Lack of efficacy - NOS | Recovered/Normal |
| May 1, 2024 | Horse | Unknown | Sodium Hyaluronate | Joint swelling | Outcome Unknown |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe, difficulty breathing, seizures, collapse, or severe swelling, seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.